Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
Authors
Keywords
Wild Type Mouse, Dentate Gyrus, Probe Trial, Saline Group, Escape Latency
Journal
Alzheimers Research & Therapy
Volume 5, Issue 2, Pages 20
Publisher
Springer Nature
Online
2013-04-19
DOI
10.1186/alzrt174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State of the Science
- (2013) Deirdre Brett Fraller JOURNAL OF NEUROSCIENCE NURSING
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease
- (2011) Christian Hölscher BIOCHEMICAL SOCIETY TRANSACTIONS
- Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice
- (2011) Emilie Faivre et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis
- (2011) Emilie Faivre et al. JOURNAL OF NEUROPHYSIOLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Proinflammatory cytokines, sickness behavior, and Alzheimer disease
- (2011) C. Holmes et al. NEUROLOGY
- Inflammation and Alzheimer’s disease
- (2010) Young-Jung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases
- (2010) Cláudia P. Figueiredo et al. BEHAVIOURAL PHARMACOLOGY
- Insulin receptor signaling in the development of neuronal structure and function
- (2010) Shu-Ling Chiu et al. Neural Development
- Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
- (2010) Simon Gengler et al. NEUROBIOLOGY OF AGING
- Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): Cellular localization, lesion-affected expression, and impaired regenerative axonal growth
- (2009) Bettina A. Buhren et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
- (2009) M. Blurton-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Do rats really express neophobia towards novel objects? Experimental evidence from exposure to novelty and to an object recognition task in an open space and an enclosed space
- (2008) A. Ennaceur et al. BEHAVIOURAL BRAIN RESEARCH
- Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
- (2008) Victor A. Gault et al. JOURNAL OF NEUROPHYSIOLOGY
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started